Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

VRHI
Veri Medtech Holdings Inc.

Common Stock

0.60

0.1876

45.49%

0.402 / 0.69 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/18/2025
Delayed (15 Min) Trade Data: 12:00am 07/18/2025
OTC Disclosure & News Service

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings (OTC Markets: “VRHI”) ("Veri Medtech") announced today that its powerful network of licensed physicians has now grown to 400, forming an Infinite Wellness Loop.

“Having a strong network of licensed physicians is key to the success of any provider of telemedicine products and services.   Veri Medtech’s proprietary technology platform seamlessly matches patients with physicians, in order to deliver quality care to anyone, anywhere, anytime. Platform + Patients + Physicians = Infinite Wellness Loop: This is what sets Veri Medtech (VRHI) separate and apart, and second to none. There is more news to come,” said Sam Adetunji, CEO, Veri Medtech Holdings.

About Veri Medtech (OTC Markets: VRHI): Veri Medtech is a leading provider of health and wellness services and products, via its proprietary healthcare technology platform.  Veri Medtech is strategically positioned to explore untapped opportunities, including the acquisition of complementary healthcare companies. This strategic growth approach allows us to leverage our technological advantage, expanding our offerings to a broader audience. Our successful track record in completing similar acquisitions ensures the swift integration of new patient databases, providing us with an instant avenue for revenue growth and a wider pool of patients open to diverse healthcare opportunities.  For more information, please visit: www.VeriMedTech.com

About Global Telemedicine:  The global telemedicine market size was valued at USD 114.98 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.96% from 2024 to 2030.  Telemedicine market growth is being driven by factors such as consolidation across industry, strategic initiatives by key companies, and increasing healthcare consumerism. Furthermore, rising adoption of telemedicine by providers, increasing patient acceptance and consumer demand, and delivery of improved quality of care are expected to contribute to the growth of the telemedicine market over the forecast period. For instance, in May 2021, Walmart Inc. acquired a telehealth company, MeMD. This acquisition is expected to enable Walmart to expand its offerings and provide virtual access to primary, urgent, and behavioral healthcare services nationwide. Source: Grandview Research. https://www.grandviewresearch.com/industry-analysis/telemedicine-industry

About Prescription Products and Services:  Certain products and services available through Veri Medtech can be purchased only with a prescription from a qualified medical provider. To access these products, you must first consult with a medical provider through our proprietary technology platform.  We make this process simple and convenient. Through Veri Medtech, you can access a network of medical providers who can evaluate your specific needs based on your health information, and if appropriate, prescribe treatment.  For more information, please visit: www.VeriMedTech.com

Forward Looking Statements: Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Veri Medtech (OTC: "VRHI") and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.


Press Release Inquiries: pr@verimedtech.com
OTCID Market Logo
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.